You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

Article metrics

Article menu

Download PDFPDF

XML
Review
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2026

AbstractFullPdf
Jan 202023230
Feb 202074740
Mar 202063631
Apr 202054549
May 202011011041
Jun 2020454521
Jul 2020212128
Aug 2020373539
Sep 2020535341
Oct 2020696993
Nov 2020696959
Dec 2020616159
Jan 2021626245
Feb 2021737358
Mar 2021636346
Apr 2021707048
May 2021535339
Jun 2021737370
Jul 2021636349
Aug 2021737279
Sep 2021626242
Oct 2021797980
Nov 2021737365
Dec 2021717342
Jan 2022838541
Feb 2022929649
Mar 202214815359
Apr 202210110252
May 2022797947
Jun 2022656540
Jul 2022838642
Aug 2022757724
Sep 2022757628
Oct 2022676932
Nov 2022798259
Dec 2022707328
Jan 2023585831
Feb 2023616424
Mar 2023697031
Apr 2023676931
May 2023666633
Jun 2023565716
Jul 2023757514
Aug 2023686822
Sep 2023797954
Oct 2023606023
Nov 2023616132
Dec 2023737327
Jan 2024747432
Feb 2024959741
Mar 2024858553
Apr 2024767730
May 2024686825
Jun 2024636524
Jul 2024585816
Aug 2024303118
Sep 2024232319
Oct 2024515227
Nov 2024798328
Dec 202418118471
Jan 2025525225
Feb 2025595935
Mar 2025595916
Apr 202511211227
May 2025555626
Jun 2025434311
Mar 2026110
Total456846152417